ATXI - アベニュ―・セラピュ―ティクス (Avenue Therapeutics Inc.) アベニュ―・セラピュ―ティクス

 ATXIのチャート


 ATXIの企業情報

symbol ATXI
会社名 Avenue Therapeutics Inc (アベニュ―・セラピュ―ティクス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 医薬品   医療関連(Health Care)
概要 事業概要 Avenue Therapeutics Inc. is a pharmaceutical company. The Company is engaged in acquiring licensing developing and commercializing products principally for use in the acute or intensive care hospital setting. Its product candidate is intravenous (IV) Tramadol an intravenous formulation of tramadol hydrochloride (HCl) for the management of moderate to moderately severe postoperative pain. Tramadol a synthetic dual-acting opioid is a centrally acting analgesic with weak opioid agonist properties. It also works via the inhibition of serotonin and noradrenaline re-uptake and blocking nociceptive impulses at the spinal level. Tramadol is also combined with acetaminophen (APAP) or nonsteroidal anti-inflammatory drugs (NSAIDS) in clinical practice. During the year ending December 31 2016 the Company had completed a pharmacokinetics (PK) study for IV Tramadol in healthy volunteers.   アベニュ―・セラピュ―ティクスは米国の専門医薬品企業。主に手術後の中程度から重度の疼痛緩和に特化した医薬品の開発・商品化に従事する。合成二重作用性オピオイドで有効性と安全性のあるトラマド―ルHCIの臨床デ―タを活用し、トラマド―ルHCI静脈内製剤の開発に焦点を当てる。本社はニューヨーク。   Avenue Therapeutics is a specialty pharmaceutical company whose mission is to develop IV tramadol, a potential alternative that could reduce the use of conventional opioids, for patients suffering from acute pain in the U.S. Avenue is headquartered in New York City and was founded by Fortress Biotech, Inc.
本社所在地 2 Gansevoort Street 9th Floor New York NY 10014 USA
代表者氏名
代表者役職名
電話番号 +1 781-652-4500
設立年月日 42125
市場名 NASDAQ Small Cap
ipoyear 2017年
従業員数
url www.avenuetx.com
nasdaq_url https://www.nasdaq.com/symbol/atxi
adr_tso
EBITDA EBITDA(百万ドル) -24.27900
終値(lastsale) 2.36
時価総額(marketcap) 24908431.2
時価総額 時価総額(百万ドル) 26.38605
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 17.44605
当期純利益 当期純利益(百万ドル) -24.22500
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Avenue Therapeutics Inc revenues was not reported. Net loss increased from $3.1M to $15M. Higher net loss reflects Research and development increase from $580K to $13.2M (expense) General and administrative increase of 15% to $1.9M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.37 to -$1.48.

 ATXIのテクニカル分析


 ATXIのニュース

   The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts  2021/07/27 11:48:32 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI ) (IPOed Thursday) Arvinas, Inc. (NASDAQ: ARVN ) BioNTech SE (NASDAQ: BNTX ) ( disclosed plans to make mRNA vaccine for malaria by 2022) Cassava Sciences, Inc. (NASDAQ: SAVA ) (announced positive data for SavaDx, an investigational diagnostic/biomarker to detect Alzheimer''s disease with a simple blood test) Eli Lilly and Company (NYSE: LLY ) Moderna, Inc. (NASDAQ: MRNA ) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE ) NanoVibronix, Inc. (NASDAQ: NAOV ) (announced first shipment of its next generation pain management device, PainShield Plus) Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) Sight Sciences, Inc. (NASDAQ: SGHT ) (IPOed July 15) Translate Bio, Inc. (NASDAQ: TBIO ) (moved on positive analyst action) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 26) 23andMe Holding Co. (NASDAQ: ME ) AbCellera Biologics Inc.
   The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street  2021/07/20 12:19:55 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated (NASDAQ: CYTK ) ( announced topline results from Cohorts 1 and 2 of the Phase 2 study of CK-274 in obstructive outflow disease in hypertrophic cardiomyopathy) Forward Pharma A/S (NASDAQ: FWP ) ResMed Inc. (NYSE: NRMD) Legend Biotech Corporation (NASDAQ: LEGN ) Moderna, Inc. (NASDAQ: MRNA ) ( extended gains on recent momentum) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 19) 4D pharma plc (NASDAQ: LBPS ) Adaptimmune Therapeutics plc (NASDAQ: ADAP ) Adverum Biotechnologies, Inc. (NASDAQ: ADVM ) Aerovate Therapeutics, Inc. (NASDAQ: AVTE ) (IPOed June 30) Agile Therapeutics, Inc. (NASDAQ: AGRX ) Allena Pharmaceuticals, Inc. (NASDAQ: ALNA ) Alzamend Neuro, Inc. (NASDAQ: ALZN ) Aptose Biosciences Inc. (NASDAQ: APTO ) ARCA biopharma, Inc. (NASDAQ: ABIO ) Ascendis Pharma A/S (NASDAQ: ASND ) Assembly Biosciences, Inc.
   The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs  2021/07/15 12:07:56 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) - U.K. antitrust regulators cleared its pending acquisition by AstraZeneca PLC (NASDAQ: AZN ) Bristol-Myers Squibb Company (NYSE: BMY ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Moderna, Inc. (NASDAQ: MRNA ) PLx Pharma Inc. (NASDAQ: PLXP ) Zoetis Inc. (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 14) 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT ) 89bio, Inc. (NASDAQ: ETNB ) AbCellera Biologics Inc. (NASDAQ: ABCL ) Achilles Therapeutics plc (NASDAQ: ACHL ) Adicet Bio, Inc. (NASDAQ: ACET ) Adverum Biotechnologies, Inc. (NASDAQ: ADVM ) Akero Therapeutics, Inc. (NASDAQ: AKRO ) Allena Pharmaceuticals, Inc. (NASDAQ: ALNA ) ( announced a registered direct offering) Allogene Therapeutics, Inc. (NASDAQ: ALLO ) AlloVir, Inc. (NASDAQ: ALVR ) Aptose Biosciences Inc. (NASDAQ: APTO ) Avenue Therapeutics, Inc.
   The Daily Biotech Pulse: ScPharma''s Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues  2021/07/14 11:48:12 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Biohaven Pharmaceutical Holding Company Ltd. . (NYSE: BHVN ) AngioDynamics, Inc. (NASDAQ: ANGO ) (reacted to its fiscal-year 2021 fourth-quarter results) Bicycle Therapeutics plc (NASDAQ: BCYC ) ( announced Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ) exercised option to use its tissue-targeted delivery of oligonucleotide therapeutics tech) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Forward Pharma A/S (NASDAQ: FWP ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) PLx Pharma Inc. (NASDAQ: PLXP ) (announced availability of FDA-approved liquid-filled aspirin capsules in Walmart Inc. (NYSE: WMT ) stores) Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX ) Unicycive Therapeutics, Inc. (NASDAQ: UNCY ) (IPOed Tuesday) Zoetis Inc. (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 13) AbCellera Biologics Inc. (NASDAQ: ABCL ) Achilles Therapeutics plc (NASDAQ: ACHL ) Adicet Bio, Inc.
   Petco Health and Wellness, Vroom among premarket losers'' pack  2021/06/15 12:21:30 Seeking Alpha
   Avenue Therapeutics Inc Shares Close the Week 28.9% Higher - Weekly Wrap  2021/04/23 22:30:00 Kwhen Finance
Avenue Therapeutics Inc shares closed this week 28.9% higher than it did at the end of last week. The stock is currently down 15.3% year-to-date, down 43.9% over the past 12 months, and down 38.9% over the past five years. This week, the Dow Jones Industrial Average rose 0.5%, and the S&P 500 rose 1.3%. Trading Activity Shares traded as high as $5.15 and as low as $3.85 this week.Trading volume this week was 33.6% lower than the 10-day average and 68.6% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -183.1% The company's stock price performance over the past 12 months lags the peer average by -167.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Avenue Therapeutics Inc Shares Close the Week 33.8% Lower - Weekly Wrap  2021/04/16 22:30:00 Kwhen Finance
Avenue Therapeutics Inc shares closed this week 33.8% lower than it did at the end of last week. The stock is currently down 23.7% year-to-date, down 50.2% over the past 12 months, and down 45.0% over the past five years. This week, the Dow Jones Industrial Average rose 1.2%, and the S&P 500 rose 1.4%. Trading Activity Shares traded as high as $5.25 and as low as $3.91 this week.Trading volume this week was 70.0% lower than the 10-day average and 42.3% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -340.4% The company's stock price performance over the past 12 months lags the peer average by -181.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Avenue Therapeutics Inc. Shares Close the Day 11.1% Lower - Daily Wrap  2021/03/17 22:30:00 Kwhen Finance
Avenue Therapeutics Inc. shares closed today 11.1% lower than it did at the end of yesterday. The stock is currently up 2.5% year-to-date, down 5.3% over the past 12 months, and down 26.1% over the past five years. Today, the Dow Jones Industrial Average fell 0.4%, and the S&P 500 fell 1.5%. Trading Activity Shares traded as high as $6.98 and as low as $6.10 this week.Shares closed 5e+1% below its 52-week high and 1e+2% above its 52-week low.Trading volume this week was 57.9% lower than the 10-day average and 75.0% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -61.0% The company's stock price performance over the past 12 months lags the peer average by -125.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Avenue Therapeutics Inc. Shares Close the Week 28.7% Higher - Weekly Wrap  2021/03/05 22:30:00 Kwhen Finance
Avenue Therapeutics Inc. shares closed this week 28.7% higher than it did at the end of last week. The stock is currently up 1.7% year-to-date, down 30.1% over the past 12 months, and down 26.7% over the past five years. This week, the Dow Jones Industrial Average rose 1.9%, and the S&P 500 rose 0.9%. Trading Activity Shares traded as high as $7.27 and as low as $4.87 this week.Trading volume this week was 75.0% lower than the 10-day average and 43.2% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.4. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -68.7% The company's stock price performance over the past 12 months lags the peer average by 211.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Avenue Therapeutics Inc. Shares Close the Week 23.1% Lower - Weekly Wrap  2021/02/19 22:30:00 Kwhen Finance
Avenue Therapeutics Inc. shares closed this week 23.1% lower than it did at the end of last week. The stock is currently down 9.9% year-to-date, down 45.9% over the past 12 months, and down 35.0% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 fell 0.7%. Trading Activity Shares traded as high as $6.98 and as low as $5.12 this week.Trading volume this week was 58.8% lower than the 10-day average and 34.1% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -143.5% The company's stock price performance over the past 12 months lags the peer average by -570.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

 関連キーワード  (医薬品 米国株 アベニュ―・セラピュ―ティクス ATXI Avenue Therapeutics Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)